Anhidrotic Area and Safety of MEDITOXIN in Healthy Male Valunteers

Phase 1CompletedNCT03647982

Medy-Tox13 enrolled

Overview

To determine the anhidrotic area and safety of MEDITOXIN

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Anhidrotic Area Hyperhidrosis

Interventions

MeditoxinDRUG

injection of MEDITOXIN into the intradermal of each contralateral upper back in equal doses

BotoxDRUG

injection of Botox into the intradermal of each contralateral upper back in equal doses

Eligibility

Sex: MALEMin age: 20 YearsMax age: 45 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Male adults aged between 20 and 45 years Exclusion Criteria: * Subjects not appropriate for participating in this study according to the investigator's opinion

Locations (1)

Catholic University St. Paul Hospital

Seoul, Dongdaemun-gu, South Korea

Outcomes

Primary Outcomes

anhidrotic area

After the ninhydrin sweat test, measure the area of the unstained area

Time frame: week 4

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.